Should I buy Invesco (IVZ) stock or is it too late?

Invesco · Financials · price $33

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: RBC Capital — 74% of its targets hit on this sector (476 calls tested). It aims for $35 (+5.1 %), call made on July 30, 2026, maturing on July 30, 2027 (29 d ago).

The 6 reliable analysts $33.50+0.6 %

The 2 other firms $29-13 %

How to read it: the 6 reliable firms are not filtered by optimism — 3 aim above the price, 3 below, hence their $33.50 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Invesco

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
JP Morgan	73 %	+13.8 %	11	$30 -11%
Deutsche Bank	41 %	+11.4 %	29	$31 -7%
Keefe, Bruyette & Woods	58 %	+4.8 %	12	$20 -41%
Barclays	37 %	-11.8 %	19	$32 -4%
Citigroup	37 %	-35.5 %	19	$25 -25%
UBS	80 %	+29.2 %	5	—
Jefferies	67 %	+9.7 %	12	—
Credit Suisse	38 %	-6.7 %	8	—

In short — Should you invest in Invesco? Is it too late, still worth it? Analysts are split (38% buy, median target $31, i.e. -7%). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Pays a dividend (3.1% yield) — regular income on top of potential upside.

⚠️ Reasons to hesitate

Even the most reliable firm on IVZ, Morgan Stanley (100% hit rate, 2 scored calls), only targets $30 (call made on July 17, 2026, maturing on July 17, 2027) (-10%) in its most recent call, and $26 (call made on October 6, 2025, maturing on October 6, 2026) (-22%) in the one coming due soonest. The stock may already have run past its target.
The consensus is not unanimous: of 8 ratings, 5 are neutral.
Limited upside: the median target is only -7% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on IVZ

Median target $31 (-7%) · 8 ratings · Hold consensus

Strong Buy00%

Buy338%

Hold563%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Invesco now?

We won't decide for you. The facts: 38% of analysts rate it a buy, median target $31 (-7%), and Morgan Stanley (most reliable on IVZ, 100%) targets $30. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Invesco?

The stated upside is small: the median target ($31) sits just -7% from the price ($33) (most reliable on IVZ: Morgan Stanley, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Invesco still worth investing in?

It depends on the gap between the price ($33) and its estimated value: analysts target $31 on median (-7%), with 38% buys (most reliable on IVZ: Morgan Stanley, 100%). Cross-check with their real reliability on IVZ and the cautions above. Information, not advice.

What's the main risk in buying IVZ?

Even the most reliable firm on IVZ, Morgan Stanley (100% hit rate, 2 scored calls), only targets $30 (call made on July 17, 2026, maturing on July 17, 2027) (-10%) in its most recent call, and $26 (call made on October 6, 2025, maturing on October 6, 2026) (-22%) in the one coming due soonest. The stock may already have run past its target.

→ Go deeper: the full Invesco profile (consensus, analyst reliability, price target, performance).